Collaborative Covid Immunology logo with shield


Collaborative Covid Immunology: A UK-CIC Conference’ took place on Wednesday 28 April and Thursday 29 April 2021.

This event was the UK Coronavirus Immunology Consortium’s flagship virtual scientific conference, and brought consortium collaborators together with members of the wider immunology community to discuss the latest in COVID-19 immunology research.

More than 450 participants joined us online for this unique opportunity. The programme included sessions on primary and protective immunity, immunopathology, cross-reactive coronavirus immunity, and immune evasion. Attendees were also able to connect in focused chat room discussions, as well as virtual posters and speed-networking.

The UK-CIC conference was funded by UK Research and Innovation (UKRI) and the National Institute for Health Research (NIHR), and supported by the British Society for Immunology. 


Click below to watch recordings of many of the presentations at the conference.

These will be available until Wednesday 4 August 2021. 


Emily Stephenson (Newcastle University, UK)

The cellular immune response to COVID-19 deciphered by single cell multi-omics across three UK centres


Omer Bayraktar (Wellcome Sanger Institute, UK)

Spatial transcriptomic discovery of pathological phenotypes across COVID19 infected human tissues


Paul Morgan (Cardiff University, UK)

Complement and complement therapies in Covid-19


Victoria Hall (Public Health England, UK)

Immunity studies in Health Care Workers – what have we learned?


Ane Ogbe (University of Oxford, UK)

T cell responses against SARS-CoV-2 in a cohort of frontline Healthcare workers (HCWs) – The PITCH study


Alex Richter (University of Birmingham, UK)

Antibody responses and Immunity


Ryan Thwaites (Imperial College London, UK)

Patterns of inflammatory responses in COVID vs. severe influenza


Wendy Barclay (Imperial College London, UK)

Risk Assessing Variants of SARS-CoV-2


Richard Stanton (Cardiff University, UK)

ADNKA overcomes SARS-CoV2-mediated NK cell inhibition through non-spike antibodies


David Robertson (University of Glasgow, UK)

The evolution of SARS-CoV-2


Leo Swadling (University College London, UK)

ORF-1-specific cross-reactive T cells


Thushan de Silva (University of Sheffield, UK)

The impact of viral mutations on recognition by SARS-CoV-2 specific T-cells


Tony Kelly (UK-CIC PPI representative, UK)

Patient and Public Involvement perspective on UK-CIC


Susan Hopkins (NHS Test & Trace; NHS England; Public Health England, UK)

SIREN: How it began and early evidence


Barney Graham (Vaccine Research Center, NIAID, NIH, USA)

Rapid COVID-19 Vaccine Development


You can view or download all conference abstracts here.